These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23097688)

  • 1. Polymer-drug conjugates for intracellar molecule-targeted photoinduced inactivation of protein and growth inhibition of cancer cells.
    Wang B; Yuan H; Zhu C; Yang Q; Lv F; Liu L; Wang S
    Sci Rep; 2012; 2():766. PubMed ID: 23097688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER+ breast cancer.
    Chauhan K; Hernandez-Meza JM; Rodríguez-Hernández AG; Juarez-Moreno K; Sengar P; Vazquez-Duhalt R
    J Nanobiotechnology; 2018 Feb; 16(1):17. PubMed ID: 29463260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethoxy mansonone G as an anticancer agent in estrogen receptor-positive and endocrine-resistant breast cancer.
    Chonsut P; Mahalapbutr P; Pradubyat N; Chavasiri W; Wonganan P; Ketchart W
    J Pharm Pharmacol; 2019 Dec; 71(12):1839-1853. PubMed ID: 31588558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.
    Kim J; Lee J; Jang SY; Kim C; Choi Y; Kim A
    Oncol Rep; 2016 May; 35(5):2553-60. PubMed ID: 26986571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate.
    Fernandez Gacio A; Fernandez-Marcos C; Swamy N; Dunn D; Ray R
    J Cell Biochem; 2006 Oct; 99(3):665-70. PubMed ID: 16795032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ.
    Mishra AK; Abrahamsson A; Dabrosin C
    Oncotarget; 2016 Aug; 7(35):56876-56888. PubMed ID: 27486755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent tamoxifen-encapsulated nanocapsules functionalized with folic acid for enhanced drug delivery toward breast cancer cell line MCF-7 and cancer cell imaging.
    Nankali E; Shaabanzadeh M; Torbati MB
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Jul; 393(7):1211-1219. PubMed ID: 31980856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
    Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
    Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loaded nanostructured lipid carriers.
    Beh CY; How CW; Foo JB; Foong JN; Selvarajah GT; Rasedee A
    Drug Des Devel Ther; 2017; 11():771-782. PubMed ID: 28352153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic action of permanently charged tamoxifen derivatives via estrogen receptor-alpha.
    Rivera-Guevara C; Pérez-Alvarez V; García-Becerra R; Ordaz-Rosado D; Morales-Ríos MS; Hernández-Gallegos E; Cooney AJ; Bravo-Gómez ME; Larrea F; Camacho J
    Bioorg Med Chem; 2010 Aug; 18(15):5593-601. PubMed ID: 20621492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial-mesenchymal transition, decreased ERα expression and AKT activation.
    Liang YK; Zeng D; Xiao YS; Wu Y; Ouyang YX; Chen M; Li YC; Lin HY; Wei XL; Zhang YQ; Kruyt FA; Zhang GJ
    Cancer Lett; 2017 Feb; 386():65-76. PubMed ID: 27838413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer.
    Tang C; Li C; Zhang S; Hu Z; Wu J; Dong C; Huang J; Zhou HB
    J Med Chem; 2015 Jun; 58(11):4550-72. PubMed ID: 25993269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Estrogen-Regulated
    Zhang W; Wu M; Chong QY; Zhang M; Zhang X; Hu L; Zhong Y; Qian P; Kong X; Tan S; Li G; Ding K; Lobie PE; Zhu T
    Cancer Res; 2018 Sep; 78(17):4915-4928. PubMed ID: 29945962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on tamoxifen encapsulated in lipid vesicles: effect on the growth of human breast cancer MCF-7 cells.
    Bhatia A; Bhushan S; Singh B; Katare OP
    J Liposome Res; 2009; 19(3):169-72. PubMed ID: 18991067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
    Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
    Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin reverses tamoxifen resistance in breast cancer cells.
    Wang H; Tao L; Qi K; Zhang H; Feng D; Wei W; Kong H; Chen T; Lin Q
    J BUON; 2015; 20(3):707-13. PubMed ID: 26214621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel flexible ester-containing analogs of tamoxifen and their evaluation as anticancer agents.
    Elghazawy NH; Engel M; Hartmann RW; Hamed MM; Ahmed NS; Abadi AH
    Future Med Chem; 2016; 8(3):249-56. PubMed ID: 26898104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual functional small molecule fluorescent probes for image-guided estrogen receptor-specific targeting coupled potent antiproliferative potency for breast cancer therapy.
    Yang L; Hu Z; Luo J; Tang C; Zhang S; Ning W; Dong C; Huang J; Liu X; Zhou HB
    Bioorg Med Chem; 2017 Jul; 25(13):3531-3539. PubMed ID: 28506582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological, Mechanistic, and Pharmacokinetic Assessment of Novel Melatonin-Tamoxifen Drug Conjugates as Breast Cancer Drugs.
    Hasan M; Marzouk MA; Adhikari S; Wright TD; Miller BP; Matossian MD; Elliott S; Wright M; Alzoubi M; Collins-Burow BM; Burow ME; Holzgrabe U; Zlotos DP; Stratford RE; Witt-Enderby PA
    Mol Pharmacol; 2019 Aug; 96(2):272-296. PubMed ID: 31221824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Molecular Combination of Zinc(II) Phthalocyanine and Tamoxifen Derivative for Dual Targeting Photodynamic Therapy and Hormone Therapy.
    Zhang FL; Song MR; Yuan GK; Ye HN; Tian Y; Huang MD; Xue JP; Zhang ZH; Liu JY
    J Med Chem; 2017 Aug; 60(15):6693-6703. PubMed ID: 28699738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.